宝利国际(300135.SZ)第三季度净利润预增188.21%-196.94%
格隆汇 10 月 14日丨宝利国际(300135.SZ)公布,预计2020年前三季度归属于上市公司股东的净利润295万元-315万元,同比下降91.87%-92.39%;其中,第三季度归属于上市公司股东的净利润3300万元-3400万元,同比增长188.21%-196.94%。
公司2020年前三季度业绩变动的主要原因是:2020年1-6月,受新冠疫情影响,公司归属于上市公司股东利润亏损3076万元。第三季度,公司积极推进受疫情影响而延期履行的订单及新签署订单的生产供应,扭转了亏损的局面。
2020年前三季度非经常性损益对净利润的影响金额约为1250万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.